Hot
Biotinylated Human CX3CL1 Protein, His Tag, ultra sensitivity (primary amine labeling)Cat. No. CX1-H8221
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| CX3CL1 | HOT CX1-H8221 | Biotinylated Human CX3CL1 Protein, His Tag, ultra sensitivity (primary amine labeling) | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | |
| CX3CL1 | Cynomolgus CX3CL1 / Fractalkine Protein, His Tag (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 50ug | ||
| CX3CL1 | Human CX3CL1 / Fractalkine Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $300.00 50ug | ||
| CX3CL1 | Avitag CX1-H82E6 | Biotinylated Human CX3CL1 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Quetmolimab | E-6011; KANAB-001 | Phase 2 Clinical | Eisai Co Ltd | Arthritis, Rheumatoid; Cholangitis, Sclerosing; Crohn Disease | Details |